Topic List : Cancer
Potential skin cancer treatment
Stanford researchers have learned how basal cell carcinoma evades drug treatment without mutating. The researchers found possible drug targets that may allow for more personalized treatment of this common skin cancer.
'Vaccine’ destroys tumors in mice
Activating T cells in tumors eliminated even distant metastases in mice, Stanford researchers found. Lymphoma patients are being recruited to test the technique in a clinical trial.
Breast cancer mortality drops
Six groups of researchers, including one from Stanford, collaborated to study the effect of advances in breast cancer screening and treatment on mortality rates.
Screen could reveal immunotherapy targets
Stanford scientists have developed a biochemical screen that identifies molecules critical to immunotherapy for a host of diseases, including cancer.
Chemotherapy declines for breast cancer
Chemotherapy use for early stage breast cancer declined from 2013 to 2015, possibly due to a preference for less toxic treatments, according to researchers at Stanford and the University of Michigan.
Second ‘don’t eat me’ signal found on cancer
CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.
Possible new cell therapy for leukemia
Instead of targeting a molecule called CD19 on the surface of the cancer cells, the new therapy targets a molecule called CD22.
Distinguishing features of high-value care
Two novel Stanford studies have uncovered attributes of high-quality, low-cost care for cancer and primary care patients.
Cancer research funds awarded
Maximilian Diehn, Sanjiv “Sam” Gambhir, Ash Alizadeh and Young-Jun Jeon will work on “dream teams” aiming to improve detection of cancer.
Center to support cancer immunotherapy
Stanford is one of four institutions to receive National Cancer Institute funding to analyze patients’ immune function and tumor profiles as part of a public-private partnership to accelerate cancer therapies.